The company will continue operating as Pharmapak and retain its 100 employees
Singapore: US-based Catalant Pharma Solutions announced the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business. The deal will help Catalant complement its softgel business and provide regional packaging capabilities for supply across Asia Pacific region.
Mr Mark Bisset, president, APAC, said, "This acquisition complements our industry-leading oral dosage form development and manufacturing capabilities with a broader range of packaging options, from bulk supply to finished packs."
He further added that the company will continue operating as Pharmapak and retain its 100 employees, including the leadership team at its existing facility in Dee Why, New South Wales.
Pharmapak specializes in primary and secondary packaging of oral pharmaceutical dose forms including blisters, bottles and a wide range of tertiary packaging services.
